A, T., S, L., A, K., U, P., NM, G. P., C, D., . . . Y, H. (2018). Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis. Dove Medical Press.
Chicago Style (17th ed.) CitationA, Tufail, et al. Post-marketing Surveillance Study of the Safety of Dexamethasone Intravitreal Implant in Patients with Retinal Vein Occlusion or Noninfectious Posterior Segment Uveitis. Dove Medical Press, 2018.
MLA (8th ed.) CitationA, Tufail, et al. Post-marketing Surveillance Study of the Safety of Dexamethasone Intravitreal Implant in Patients with Retinal Vein Occlusion or Noninfectious Posterior Segment Uveitis. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.